Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

The document concludes that effectively managing PCOS requires a multifaceted approach.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

The conclusion is that lifestyle changes and weight loss are first-line treatments for infertility due to anovulation, with various medications and assisted reproductive technologies as additional options.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Minoxidil effectively treats female pattern hair loss.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.